In today's Washington Post article "Calcium and Vitamin D findings show that caring for your bones can be compilicated," NOF's senior clinical director, Dr. Felicia Cosman helps clear up some of the confusion around the recent and conflicting research on calcium and vitamin D. She says: "It’s confusing, even for doctors. But there’s a common thread: None of the heart or kidney risks were associated with calcium from food. That has changed how many physicians advise their patients, and it has brought their focus back to what their patients eat. Most of the data show that dietary calcium is better for you and your bone integrity, so if you can get the calcium you need through your diet, you shouldn’t take a calcium supplement.”
Read the full article to learn more.
Last week, a Food and Drug Administration (FDA) Panel voted that the risks of calcitonin salmon outweigh the benefits for the treatment of postmenopausal osteoporosis. The panel joined health authorities around the world in reviewing the drug’s safety after two recent studies showed slightly higher rates of cancer among patients taking calcitonin. The panel voted against continued use of the drug by a narrow majority, pointing out that it has not been found very effective in preventing bone fractures.
CIRCA, the leading international buyer of fine jewelry, diamonds and watches, announced a new partnership with NOF at a Generations of Strength luncheon at the Friars Club in New York City on February 26. To kick-off the partnership, CIRCA’s Acting CEO Mary L. Forté presented NOF Executive Director and CEO Amy Porter with a check for $25,000, to support NOF’s mission.
In response to the U.S. Preventive Services Task Force’s (USPSTF) recommendation stating that there is insufficient evidence to assess the balance of benefits and harms of calcium and vitamin D supplementation for the primary prevention of fractures, the National Osteoporosis Foundation (NOF) reminds the public that both nutrients are an important part of bone health management.